1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type ; Treatment, and Geography

Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type ; Treatment, and Geography

  • March 2021
  • 189 pages
  • ID: 6063376
  • Format: PDF
  • The Insight Partners
Up to $1710 off Until Jul 31st 2021

Summary

Table of Contents

Search Inside

The global allergy treatment market is expected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2020 to 2028.

Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are the factors driving the global allergy treatment market growth. However, the lack of awareness about allergies and their treatments are hindering the market growth.

The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body.Dust mite, animal dander, cockroach, pollens, mold, food substances, and metal and element particles are among the common allergens.

While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them.

Immunotherapy is offered in two different types—allergy shots and sublingual immunotherapy (SLIT).Allergy shots are the extracts of allergens that are administered with increasing dosage; they are effective for allergies caused by asthma, pets, dust, pollen, bees, and other stinging insects.

Generally, SLIT tablets are administered daily by keeping them under the tongue; this type is an effective treatment option for nasal allergies and asthma.The administration of repetitive dosage of allergen makes patients less sensitive to that allergen, thus providing relief from allergic symptoms.

Immunotherapy has shown positive and long-term benefits in allergic patients.Moreover, it is suitable for self-administration and medicine usage in homecare settings.

Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies.

Various studies have shown that immunotherapy reduces allergic symptoms by 60–65% among the patients who have completed their dosages of allergen.According to a study published in Annals of Allergy, Asthma and Immunology Journal in February 2016, ~70% of allergy patients do not need medications for their allergic reactions.

The study also stated that immunotherapy is effective among children as well as elderly population. Thus, the increasing adoption of immunotherapy in the treatment of allergies is fueling the allergy treatment market growth.

Allergy Type Insights
Based on Rhinitis, the global allergy treatment market is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies.In 2020, the rhinitis segment held the largest share in the market, and it is expected continue to be the largest shareholder in the market by 2028.

With the significantly growing prevalence of rhinitis, probably due to frequent climatic and environmental changes, the demand for treatment groups such as decongestants, antihistamines, and topical/oral steroids is also increasing worldwide.

Treatment Insights
Based on treatment, the global allergy treatment market is segmented into anti-allergy drugs and immunotherapy.The anti-allergy drugs segment held a larger market share in 2020, and it is further expected to dominate the market by 2028.

These drugs are available in forms such as tablets, nasal sprays, inhalers, liquid, ointments, injections, and eyedrops.

Major primary and secondary sources referred to while preparing the report on the global allergy treatment market are the Annals of Allergy, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), British Society for Immunology, Global Resource in Allergy (GLORIA), European Community Respiratory Health, World Health Organization (WHO), British Skin Foundation, Food Allergy Research & Education, Allergy UK Organization (AUKO), National Library of Medicine, International Trade Administration (ITA), Center for Food Allergy Diagnosis and Treatment, The European Academy of Allergy and Clinical Immunology, American Academy of Allergy, Australian Society of Clinical Immunology and Allergy (ASCIA), and Allergy Foundation of South Africa.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

$4550

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

South America Automated Storage and Retrieval System Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and End Users

  • $ 3000
  • May 2021
  • 98 pages

The automated storage and retrieval system market in SAM is expected to grow from US$ 200.67 million in 2020 to US$ 364.46 million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028. ...

  • Central America
  • Allergy Drug
  • Industry analysis
  • Drug Approval
  • Allergy Prevalence

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on